Stifel maintains $81 price target on Agree Realty stock, keeps Buy rating
Stifel analysts reiterated their Buy rating on Agree Realty Corporation (NYSE:ADC) with a steady price target of $81.00, aligning with the broader analyst consensus that shows targets ranging from $74 ...
Stifel highlights risks in US transport sector outlook
Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while 2024 ...
Quanta Services price target raised to $388 from $374 at Stifel
Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...
Old Dominion price target raised to $193 from $176 at Stifel
Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...
The Times Leader8h
Wheeling Central’s Sancomb sets new school record with 47 points
Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...
Kits Eyecare FY2024 EPS Estimate Increased by Stifel Canada
Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.
bovnews17h
Canoo Inc (GOEV) Stock Settles at $0.37: What’s Contributing to This Price Point?
On Tuesday, Canoo Inc (GOEV) stock saw a decline, ending the day at $0.37 which represents a decrease of $-0.98 or -72.59% from the prior close of $1.35. The stock opened at $0.39 and touched a low of ...
Stifel Financial Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...
Cytokinetics started at buy by Stifel, aficamten highlighted
Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
ABL Advisor1d
Alpaca Real Estate Closes $50MM Credit Facility with Stifel Bank
Alpaca Real Estate (“ARE”), an alternative investment management firm, closed a $50 million credit facility with Stifel Bank. This financing marks another key milestone in the firm’s growth, ...
bovnews2d
Why Did Stifel Give Altimmune Inc (ALT) Stock Buy Rating?
Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...